IMRX
Immuneering Corp
NASDAQ: IMRX · HEALTHCARE · BIOTECHNOLOGY
$5.34
-0.84% today
Updated 2026-05-05
Market cap
$345.48M
P/E ratio
—
P/S ratio
563.62x
EPS (TTM)
$-1.27
Dividend yield
—
52W range
$1 – $10
Volume
0.9M
Immuneering Corp (IMRX) Earnings
Quarterly earnings history, analyst estimates, and stock price reaction.
EPS beat streak
6 of 8
Last 8 quarters
Avg EPS surprise
-8.9%
Last 4 quarters
Revenue YoY growth
—
Most recent quarter
EPS YoY growth
+83.2%
Most recent quarter
Earnings surprise history (last 12 quarters)
Beat estimate Missed estimate
Quarterly EPS and revenue trend
Quarterly revenue EPS (diluted)
How the stock reacts to earnings
Avg 1-day reaction
-3.7%
Last 2 reports
Positive reaction rate
0%
0 of 2 quarters
Largest single-day move
-4.3%
2025-11-12
| Report date | EPS actual | Surprise | Close before | Close after | 1-day reaction |
|---|---|---|---|---|---|
| 2026-03-11 | $-0.18 | +42.3% | $5.62 | $5.45 | -3.0% |
| 2025-11-12 | $-0.38 | +7.3% | $6.74 | $6.45 | -4.3% |
Quarterly earnings history
| Fiscal quarter ending | EPS estimate | EPS actual | Surprise | Revenue | YoY revenue |
|---|---|---|---|---|---|
| 2025-12-31 | $-0.31 | $-0.18 | +42.3% | — | — |
| 2025-09-30 | $-0.41 | $-0.38 | +7.3% | — | — |
| 2025-06-30 | $-0.42 | $-0.82 | -95.2% | — | — |
| 2025-03-31 | $-0.49 | $-0.44 | +10.2% | — | — |
| 2024-12-31 | $-0.45 | $-1.07 | -137.8% | $726326.00 | -100.8% |
| 2024-09-30 | $-0.55 | $-0.49 | +11.2% | — | — |
| 2024-06-30 | $-0.52 | $-0.47 | +9.6% | — | — |
| 2024-03-31 | $-0.50 | $-0.49 | +2.0% | — | — |
| 2023-12-31 | $-0.47 | $-0.52 | -10.6% | $-94.42M | — |
| 2023-09-30 | $-0.49 | $-0.43 | +12.2% | — | — |
| 2023-06-30 | $-0.53 | $-0.43 | +18.9% | $94.42M | — |
| 2023-03-31 | $-0.56 | $-0.51 | +8.9% | — | — |
Frequently asked questions
Has Immuneering Corp beaten earnings estimates?
Immuneering Corp has beaten Wall Street EPS estimates in 6 of its last 8 quarterly reports, with an average EPS surprise of -8.9% over the last 4 quarters.
How does IMRX stock react to earnings?
IMRX stock has moved an average of -3.7% in the trading day following earnings over its last 2 reports, with positive reactions in 0% of those quarters.